Abstract
BackgroundThe DAWN and DEFUSE-3 trials showed the benefit of endovascular treatment (EVT) in acute ischemic stroke patients presenting beyond 6 hours from last known well (LKW) and selected by perfusion...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have